Canopy Growth Corporation (CGC)

Canada's leading cannabis firms with U.S. exposure are gaining fresh attention. Their ability to bridge both markets gives them an advantage. Moreover, U.S. policy shifts could provide new momentum. R...

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) announced today that the Company has mailed (or mailed a notice of internet ...

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a ...

President Trump announced Monday that his administration will consider cannabis rescheduling over the next few weeks. Canopy Growth rallied 24% on the news; Canadian LPs were up across the board. Cano...

Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth an...

Canopy Growth Corporation (NASDAQ:CGC ) Q1 2026 Earnings Conference Call August 8, 2025 10:00 AM ET Company Participants Luc Mongeau - CEO & Director Thomas Carlton Stewart - Interim Chief Financial O...

Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported better-than-expected financial results for the fiscal first quarter of 2026, which saw its shares jump in early trade on Friday. For the period ...

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.37 per share a year ago.